BACKGROUND/AIMS: Ursodeoxycholic acid (UDCA) has been shown to improve serum liver tests in primary sclerosing cholangitis (PSC), but controlled trials have shown inconsistent effects on liver histology, and did not reveal a survival benefit. This pilot, randomised dose-ranging trial attempted to determine whether further enrichment of the bile acid pool with UDCA would lead to an improvement in outcome for PSC patients. METHODS: Thirty-one patients with PSC were randomised to treatment with...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record